BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 8, 2014
View Archived Issues
The discovery of a new protein target and novel compounds for the treatment of malaria
Read More
Receptos initiates phase III portion of RADIANCE trial of RPC-1063 for relapsing MS
Read More
Capricor and Janssen enter collaboration to develop cell therapies for cardiovascular applications
Read More
Cytomedix completes enrollment in RECOVER-Stroke trial of ALD-401 in cerebral ischemic stroke
Read More
Cellceutix files application to commence trials of anti-psoriasis drug Prurisol
Read More
RedHill Biopharma reports pharmacokinetic results for RHB-104
Read More
GS-9973 demonstrates promising activity in phase II trial
Read More
Vaccination with ImMucin leads to promising clinical response in phase I/II trials
Read More
High-throughput screening based on physiological function for novel indications of existing drugs
Read More
Horizon Discovery forms oncology agreement with AstraZeneca
Read More
Cenicriviroc, a dual CCR2/CCR5 inhibitor, as novel therapeutic strategy for liver fibrosis
Read More
Catalyst Pharmaceutical completes type B meeting with FDA for Firdapse
Read More
Generex Biotechnology confirms database lock for AE-37 breast cancer vaccine trial
Read More
ST-10 meets endpoints in phase III AEGIS trial for iron deficiency anemia in IBD
Read More
Cytovir ADV ready to receive orphan drug designation in Europe
Read More
e-Therapeutics provides update on phase I ETS-2101 trial
Read More
Ossianix forms research collaboration with Lundbeck
Read More
Committee recommends stopping Imbruvica study based on significant survival improvement
Read More
Abraxane plus gemcitabine receives European approval for metastatic pancreatic cancer
Read More
Orexigen Therapeutics receives new FDA action date for Contrave
Read More
Sutro Biopharma and Memorial Sloan-Kettering to produce antibodies for neuroblastoma
Read More
Qiagen launches therascreen IDH1/2 test for gliomas and collaborates with Mayo Clinic
Read More
Allergan and Medytox close licensing agreement covering neurotoxin product candidates
Read More
FDA grants orphan drug status to Alitair's Erdosteine in bronchiectasis
Read More
Japanese investigators patent novel OX1/OX2 receptor antagonists
Read More
Scil Proteins discloses new fusion proteins for cancer
Read More